[go: up one dir, main page]

MX2015014038A - Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina. - Google Patents

Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina.

Info

Publication number
MX2015014038A
MX2015014038A MX2015014038A MX2015014038A MX2015014038A MX 2015014038 A MX2015014038 A MX 2015014038A MX 2015014038 A MX2015014038 A MX 2015014038A MX 2015014038 A MX2015014038 A MX 2015014038A MX 2015014038 A MX2015014038 A MX 2015014038A
Authority
MX
Mexico
Prior art keywords
glutamic acid
pyro
protein
increasing
acid formation
Prior art date
Application number
MX2015014038A
Other languages
English (en)
Inventor
Marie Rose Van Schravendijk
Stephen Waugh
Barbara Thorne
Original Assignee
Mabxience S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mabxience S A filed Critical Mabxience S A
Publication of MX2015014038A publication Critical patent/MX2015014038A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

Un procedimiento para la conversión de un residuo de glutamina y/o ácido glutámico N-terminal de una proteína en ácido piroglutámico en un procedimiento de purificación.
MX2015014038A 2013-04-04 2014-04-03 Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina. MX2015014038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13162241 2013-04-04
PCT/EP2014/056700 WO2014161940A1 (en) 2013-04-04 2014-04-03 A method for increasing pyro-glutamic acid formation of a protein

Publications (1)

Publication Number Publication Date
MX2015014038A true MX2015014038A (es) 2016-06-02

Family

ID=48044678

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014038A MX2015014038A (es) 2013-04-04 2014-04-03 Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina.

Country Status (18)

Country Link
US (1) US10400042B2 (es)
EP (1) EP2981553A1 (es)
JP (1) JP2016523812A (es)
KR (1) KR20150138273A (es)
CN (1) CN105121469A (es)
AR (1) AR095977A1 (es)
AU (1) AU2014247034B2 (es)
BR (1) BR112015025106A2 (es)
CA (1) CA2907766A1 (es)
EC (1) ECSP15043422A (es)
HK (1) HK1221472A1 (es)
MX (1) MX2015014038A (es)
RU (1) RU2015147187A (es)
SA (1) SA515361251B1 (es)
SG (2) SG10201708088WA (es)
TW (1) TW201444863A (es)
UY (1) UY35517A (es)
WO (1) WO2014161940A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3300500T1 (sl) 2015-05-20 2020-07-31 Amgen Inc. Triazolni agonisti receptorja APJ
WO2017192485A1 (en) 2016-05-03 2017-11-09 Amgen Inc. Heterocyclic triazole compounds as agonists of the apj receptor
WO2018097944A1 (en) 2016-11-16 2018-05-31 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
EP3541803B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
EP3541802B1 (en) 2016-11-16 2025-01-01 Amgen Inc. Alkyl substituted triazole compounds as agonists of the apj receptor
US11046680B1 (en) 2016-11-16 2021-06-29 Amgen Inc. Heteroaryl-substituted triazoles as APJ receptor agonists
US11020395B2 (en) 2016-11-16 2021-06-01 Amgen Inc. Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
JOP20190100A1 (ar) * 2016-11-19 2019-05-01 Potenza Therapeutics Inc بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها
EP3676280B1 (en) * 2017-08-30 2025-03-19 Fresenius Kabi Deutschland GmbH Method for purifying anti-il-6 receptor antibodies
WO2019089335A1 (en) 2017-11-03 2019-05-09 Amgen Inc. Fused triazole agonists of the apj receptor
WO2019213006A1 (en) 2018-05-01 2019-11-07 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor
EP3643322A1 (en) * 2018-10-26 2020-04-29 Mabion SA Low aggregate anti cd20 ligand formulation
CN112110983A (zh) * 2019-06-21 2020-12-22 正大天晴药业集团股份有限公司 蛋白质的纯化方法
CN112725398B (zh) * 2019-10-29 2022-07-01 中国食品发酵工业研究院有限公司 一种具有辅助降血糖功能的豌豆肽及其制备方法
US11598116B1 (en) 2020-10-01 2023-03-07 Florida Aluminum Systems, Llc Mounting system for separating and connecting fencing slabs
HUP2400216A1 (hu) * 2024-04-17 2025-10-28 Richter Gedeon Nyrt N-terminális glutamint tartalmazó immunglobulinok tisztítására szolgáló eljárások

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132101A1 (en) * 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US8084582B2 (en) 2003-03-03 2011-12-27 Xencor, Inc. Optimized anti-CD20 monoclonal antibodies having Fc variants
DE602004032379D1 (de) 2003-12-19 2011-06-01 Novo Nordisk As Prozessierung von peptiden und proteinen
US20060286629A1 (en) * 2003-12-19 2006-12-21 Norby Inga S N Processing of Peptides and Proteins
JP4870667B2 (ja) 2004-07-20 2012-02-08 シムフォゲン・アクティーゼルスカブ 組換えポリクローナルタンパク質またはポリクローナル細胞株を構造上特徴付ける方法
KR20070072510A (ko) * 2004-08-30 2007-07-04 론자 바이올로직스 피엘씨 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피
WO2007064911A1 (en) 2005-12-02 2007-06-07 Biogen Idec Inc. Anti-mouse cd20 antibodies and uses thereof
CN103554215B (zh) 2007-10-30 2016-06-15 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化
EP2435476A4 (en) 2009-05-27 2013-04-17 Synageva Biopharma Corp ANTIBODIES OBTAINED FROM BIRDS
CN102492040B (zh) * 2011-12-29 2014-06-25 嘉和生物药业有限公司 一种抗her2或/和抗her3抗体蛋白的纯化方法

Also Published As

Publication number Publication date
RU2015147187A3 (es) 2018-02-28
SG10201708088WA (en) 2017-10-30
CN105121469A (zh) 2015-12-02
WO2014161940A1 (en) 2014-10-09
JP2016523812A (ja) 2016-08-12
CA2907766A1 (en) 2014-10-09
US20160060349A1 (en) 2016-03-03
US10400042B2 (en) 2019-09-03
HK1221472A1 (zh) 2017-06-02
UY35517A (es) 2014-10-31
EP2981553A1 (en) 2016-02-10
AU2014247034A1 (en) 2015-10-01
SA515361251B1 (ar) 2018-07-01
AU2014247034B2 (en) 2018-08-23
SG11201507815XA (en) 2015-10-29
TW201444863A (zh) 2014-12-01
KR20150138273A (ko) 2015-12-09
BR112015025106A2 (pt) 2017-10-10
AR095977A1 (es) 2015-11-25
RU2015147187A (ru) 2017-05-23
ECSP15043422A (es) 2017-03-31

Similar Documents

Publication Publication Date Title
SA515361251B1 (ar) طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين
SA517382081B1 (ar) عملية تقطير لإنتاج حمض أكريليك
IN2014CN03887A (es)
MX2017010407A (es) Proceso para la produccion de acido acrilico.
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
MX348130B (es) Transaminasas inmovilizadas y procedimiento para la preparacion y uso de transaminasa inmovilizada.
MY172080A (en) Microorganisms having putrescine productivity and process for producing putrescine using the same
MY192466A (en) Processes for the preparation of an apoptosis-inducing agent
MY183321A (en) Microorganism producing o-acetyl-homoserine and method for producing o-acetylhomoserine using the same
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
IN2014DN09097A (es)
IN2013MU01113A (es)
EA038364B9 (ru) Способ получения гидролизата биомассы с пониженным содержанием солей
MX2015010006A (es) Purificacion de proteinas mejorada a traves de una etapa de desglicosilacion.
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
MX2016005511A (es) Intermediarios y metodos para sintetizar derivados de calicheamicina.
PH12017500220A1 (en) Method for obtaining crystalline l-alanine
MY173051A (en) Microorganism having producing ability of quinolinic acid and method for producing quinolinic acid using the microorganism
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
IN2013CH05865A (es)
MX364769B (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
MX2015015346A (es) Procedimiento para la preparacion de intermediarios de acido boronico.
IN2013MU02428A (es)
GEP20176618B (en) Method for semiproducts of phenibut production
MX2014002630A (es) Produccion de alcaloides sin el aislamiento de compuestos intermediarios.